Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation

Lansoprazole is a proton-pump inhibitor that is commonly used to treat many gastric illnesses. However, little is known about its effect on sperm function. Here, we investigated the in vitro effect of LP on human sperm motility, viability, nitric oxide (NO) production, and the ability of LP to chela...

Full description

Bibliographic Details
Main Authors: Saleem Ali Banihani, Falak Hisham Khasawneh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=5;spage=460;epage=468;aulast=Banihani
_version_ 1818864622819606528
author Saleem Ali Banihani
Falak Hisham Khasawneh
author_facet Saleem Ali Banihani
Falak Hisham Khasawneh
author_sort Saleem Ali Banihani
collection DOAJ
description Lansoprazole is a proton-pump inhibitor that is commonly used to treat many gastric illnesses. However, little is known about its effect on sperm function. Here, we investigated the in vitro effect of LP on human sperm motility, viability, nitric oxide (NO) production, and the ability of LP to chelate seminal calcium. Seventy-two semen samples from normozoospermic men were tested in this study. The effects of LP at 0.375, 0.75, 1.5, and 3 μg/mL on sperm motility and viability as well as at 3 μg/mL on NO production and calcium chelation in semen were assessed. Lansoprazole at 3 μg/mL significantly decreased total and progressive sperm motility (P = 0.0021, P = 0.0256, respectively), but not sperm viability (P = 0.8763). In addition, semen samples supplemented with 3 μg/mL LP had insignificant changes (P = 0.9085) in nitrite concentrations. Moreover, LP exhibited a significant (P < 0.0001) calcium chelation effect in semen. In conclusion, LP reduced sperm motility, but not viability. The reduction in sperm motility may be due to the calcium chelating effect of LP and/or decreased Na+/K+-ATPase activity, but not an alteration in NO production. Besides, none of the tested parameters was found to be correlated with male age.
first_indexed 2024-12-19T10:34:35Z
format Article
id doaj.art-8f588748179246eaa31f627d01353fbf
institution Directory Open Access Journal
issn 1735-5362
1735-9414
language English
last_indexed 2024-12-19T10:34:35Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Research in Pharmaceutical Sciences
spelling doaj.art-8f588748179246eaa31f627d01353fbf2022-12-21T20:25:39ZengWolters Kluwer Medknow PublicationsResearch in Pharmaceutical Sciences1735-53621735-94142018-01-0113546046810.4103/1735-5362.236839Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelationSaleem Ali BanihaniFalak Hisham KhasawnehLansoprazole is a proton-pump inhibitor that is commonly used to treat many gastric illnesses. However, little is known about its effect on sperm function. Here, we investigated the in vitro effect of LP on human sperm motility, viability, nitric oxide (NO) production, and the ability of LP to chelate seminal calcium. Seventy-two semen samples from normozoospermic men were tested in this study. The effects of LP at 0.375, 0.75, 1.5, and 3 μg/mL on sperm motility and viability as well as at 3 μg/mL on NO production and calcium chelation in semen were assessed. Lansoprazole at 3 μg/mL significantly decreased total and progressive sperm motility (P = 0.0021, P = 0.0256, respectively), but not sperm viability (P = 0.8763). In addition, semen samples supplemented with 3 μg/mL LP had insignificant changes (P = 0.9085) in nitrite concentrations. Moreover, LP exhibited a significant (P < 0.0001) calcium chelation effect in semen. In conclusion, LP reduced sperm motility, but not viability. The reduction in sperm motility may be due to the calcium chelating effect of LP and/or decreased Na+/K+-ATPase activity, but not an alteration in NO production. Besides, none of the tested parameters was found to be correlated with male age.http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=5;spage=460;epage=468;aulast=Banihanihuman semen; lansoprazole; nitric oxide; sperm motility; sperm viability
spellingShingle Saleem Ali Banihani
Falak Hisham Khasawneh
Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation
Research in Pharmaceutical Sciences
human semen; lansoprazole; nitric oxide; sperm motility; sperm viability
title Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation
title_full Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation
title_fullStr Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation
title_full_unstemmed Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation
title_short Effect of lansoprazole on human sperm motility, sperm viability, seminal nitric oxide production, and seminal calcium chelation
title_sort effect of lansoprazole on human sperm motility sperm viability seminal nitric oxide production and seminal calcium chelation
topic human semen; lansoprazole; nitric oxide; sperm motility; sperm viability
url http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=5;spage=460;epage=468;aulast=Banihani
work_keys_str_mv AT saleemalibanihani effectoflansoprazoleonhumanspermmotilityspermviabilityseminalnitricoxideproductionandseminalcalciumchelation
AT falakhishamkhasawneh effectoflansoprazoleonhumanspermmotilityspermviabilityseminalnitricoxideproductionandseminalcalciumchelation